MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0064712
Sada Pharma Private Limited
Sada Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.9 Cr
Latest filing
Net profit · FY 2025
₹17.94 Lakh
Net margin 2%
EBITDA · FY 2025
₹1.97 Cr
EBITDA margin 22.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10.63 Cr
Secured borrowings
Company age
19 yrs
Est. 2007
Directors on board
4
As per MCA filings
About Sada Pharma Private Limited
Data last updated:
Sada Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 10 July 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2007PTC054755. Its GSTIN is 36AAZCS5859B1ZP (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sivaramakrishna Reddy Alla and Venkata Subba Reddy Vemireddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.9 Cr. For the same year it recorded a net profit of ₹17.94 Lakh (net margin 2%) and EBITDA of ₹1.97 Cr (EBITDA margin 22.1%). Revenue has grown at a compounded annual rate (CAGR) of 323% over five years.
As per MCA filings, the company has open charges of ₹10.63 Cr on record.
Sada Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0064712). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233TG2007PTC054755
Registration Number 054755
Incorporation Date 10 July 2007
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0064712
CIN history
Sada Pharma has one previous CIN (Corporate Identification Number): U24233AP2007PTC054755. The current CIN is U24233TG2007PTC054755, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2007PTC054755 | Current |
| U24233AP2007PTC054755 | Previous |
Key People
Sivaramakrishna Reddy Alla Director Venkata Subba Reddy Vemireddy Director Jaya Prakash Goli Director Recognitions & Rankings of Sada Pharma
Contact details
Sada Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No.5 – 35/162 2nd Floor Office No.35 Sony Business Complex Prasanthi Nagar, Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, API Manufacturers, Pharma Contract R&D
To see the full contact details of Sada Pharma Private Limited, buy the company report.
Comprehensive company report
Sada Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Sada Pharma Private Limited
FY 2025 filings availableSada Pharma Private Limited reported revenue of ₹8.9 Cr for FY 2025.
Revenue · FY 2025
₹8.9 Cr
Net profit · FY 2025
₹17.94 Lakh margin 2%
EBITDA · FY 2025
₹1.97 Cr margin 22.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
5 years · compounded
▲ 323%
EBITDA CAGR growth
5 years · compounded
▲ 291%
Revenue has grown at a compounded annual rate (CAGR) of 323% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.97 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.94 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.1% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sada Pharma Private Limited, buy the company report.
Board of directors of Sada Pharma Private Limited
Sada Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sivaramakrishna Reddy Alla Also directs: Sri Gayathri Drugs Private Limited | Director | 10 Jul 2007 | 19 Years 3 Months | Current |
| Venkata Subba Reddy Vemireddy Also directs: VJ Life Sciences Private Limited, VJ Fine Chem Private Limited | Director | 18 Sep 2019 | 7 Years 1 Months | Current |
| Jaya Prakash Goli Also directs: VJ Fine Chem Private Limited | Director | 21 Oct 2021 | 5 Years 0 Months | Current |
| Shyam Sunder Reddy Also directs: Codebt Finserve Private Limited, Finsol Connect Private Limited | Director | 10 Jun 2023 | 3 Years 4 Months | Current |
Auditor
Sada Pharma Private Limited is audited by RATNA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RATNA & ASSOCIATES | FY 2023 | 011567S |
Shareholding
The shareholding of Sada Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sada Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10.63 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Sep 2022 | 100618217 | Hdfc Bank Limited | ₹10.63 Cr | Open |
To see the full charge records of Sada Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sada Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sada Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sada Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAZCS5859B1ZP | Telangana | Active | 16 Jul 2021 |
| 29AAZCS5859B1ZK | Karnataka | Active | 29 Jul 2022 |
To see the full GST registrations and return filing status of Sada Pharma Private Limited, buy the company report.
Recent activity
Sada Pharma Private Limited has 10 board changes on record since 2007: 7 appointments and 3 cessations. The latest: Sivarami Reddy Guda ceased to be Additional Director on 20 Nov 2023.
AGM
Sada Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sada Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Sivarami Reddy Guda ceased to be Additional Director.
Appointed
Shyam Sunder Reddy was appointed as Director.
Charges
A charge with Hdfc Bank Limited of Rs. 1,062.50 Lakh registered on 16 Sep 2022 with Charge ID 100618217 was modified on 19 Sep 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,062.50 Lakh with Charge ID 100618217 was registered on 16 Sep 2022.
Appointed
Jaya Prakash Goli was appointed as Director.
Ceased
Bommareddy Rajasekhar Reddy ceased to be Additional Director.
Appointed
Venkata Subba Reddy Vemireddy was appointed as Director.
Ceased
Hemalatha Alla ceased to be Director.
Appointed
Bommareddy Rajasekhar Reddy was appointed as Additional Director.
Appointed
Sivarami Reddy Guda was appointed as Additional Director.
3 earlier events are in the company report.
Frequently asked questions
Sada Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 10 July 2007 (19+ years old) and is registered under CIN U24233TG2007PTC054755.
Sada Pharma has 4 current directors:
- Sivaramakrishna Reddy Alla - Director
- Venkata Subba Reddy Vemireddy - Director
- Jaya Prakash Goli - Director
- Shyam Sunder Reddy - Director
The latest financial statements of Sada Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sada Pharma is 36AAZCS5859B1ZP, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29AAZCS5859B1ZK (Karnataka).
The CIN (Corporate Identification Number) of Sada Pharma is U24233TG2007PTC054755. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sada Pharma was incorporated on 10 July 2007, making it 19+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sivarami Reddy Guda ceased to be Additional Director on 20 Nov 2023. Shyam Sunder Reddy was appointed as Director on 10 Jun 2023. Jaya Prakash Goli was appointed as Director on 21 Oct 2021. Sada Pharma has 10 board changes on record in total.
Yes, Sada Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0064712).
The registered office of Sada Pharma is at Flat No.5 – 35162 2nd Floor Office No.35 Sony Business Complex Prasanthi Nagar, Kukatpally, Hyderabad, Telangana, India – 500072.
Sada Pharma operates in the pharma industry, in the api manufacturers segment.